Veterinary Medicines

Nobivac CEPPi, liofilizzato per sospensione iniettabile per cani

Authorised
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
Download as PDF

Product identification

Medicine name:
Nobivac CEPPi, liofilizzato per sospensione iniettabile per cani
Active substance:
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    7.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain Cornell, Live
    5.50
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Canine distemper virus, strain Onderstepoort, Live
    4.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    4.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."